GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Cash Flow from Operations

IPDQF (Impedimed) Cash Flow from Operations : $-11.92 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Impedimed Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2024, Impedimed's Cash Receipts from Operating Activities was $4.47 Mil. Its Cash Payments was $-9.39 Mil. Its Dividends Paid was $0.00 Mil. Its Dividends Received was $0.00 Mil. Its Interest Paid was $0.00 Mil. Its Interest Received was $0.31 Mil. Its Taxes Refund Paid was $0.00 Mil. And its Cash Flow from Others was $0.00 Mil. In all, Impedimed's Cash Flow from Operations for the six months ended in Dec. 2024 was $-4.61 Mil.


Impedimed Cash Flow from Operations Historical Data

The historical data trend for Impedimed's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Cash Flow from Operations Chart

Impedimed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.26 -10.14 -11.01 -12.11 -11.81

Impedimed Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.23 -3.93 -4.53 -7.31 -4.61

Impedimed Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Impedimed's Cash Flow from Operations for the fiscal year that ended in Jun. 2024 is calculated as:

Impedimed's Cash Flow from Operations for the quarter that ended in Dec. 2024 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-11.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed  (OTCPK:IPDQF) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Impedimed's cash receipts from operating activities for the six months ended in Dec. 2024 was $4.47 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $-9.39 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $0.00 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $0.31 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Impedimed's cash payments for the six months ended in Dec. 2024 was $0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Impedimed's cash flow from others for the six months ended in Dec. 2024 was $0.00 Mil.


Impedimed Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Impedimed's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q4 2021 ImpediMed Ltd Business Results Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 09-14-2024

Q3 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024

Q2 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Limited - Special Call Transcript

By GuruFocus Research 02-14-2024